Leerink Partners initiated coverage on Revvity with a new price target

7/8/24 8:14:35 AM ET

Biotechnology: Laboratory Analytical Instruments

Industrials

Leerink Partners initiated coverage of Revvity with a rating of Outperform and set a new price target of $125.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$RVTY

Date	Price Target	Rating	Analyst
5/1/2025	$115.00	Neutral → Buy	UBS
1/10/2025	$130.00	Outperform → Mkt Perform	Bernstein
12/13/2024	$138.00	Neutral → Buy	BofA Securities
10/15/2024	$125.00 → $140.00	Equal Weight → Overweight	Barclays
8/28/2024	$130.00	Equal Weight	Wells Fargo
7/8/2024	$125.00	Outperform	Leerink Partners
6/3/2024	$115.00	Hold	Jefferies
1/16/2024	$105.00 → $125.00	Buy → Neutral	UBS